Clinical Trial Update: A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating first-line erlotinib in combination with gemcitabine for locally advanced unresectable or metastatic pancreatic cancer has been termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Tarceva (erlotinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Pancreatic Cancer | Phase 4 | Status: TERMINATED